Medication abortion pills — mifepristone and misoprostol — are effective and run a low risk of causing serious adverse events when mailed to patients, a new study shows.
The study, published Monday in the peer-reviewed publication JAMA Internal Medicine, looks at the experiences of more than 500 people who wanted to end a pregnancy between January 2020 and May 2022.
Researchers conducted a cohort study that included patients from 11 abortion clinics and primary care clinics across seven states.